Try our Advanced Search for more refined results
July 20, 2016
ASTRAZENECA AB et al v. AUROBINDO PHARMA LIMITED et al
Case Number:
3:16-cv-04414
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 21, 2016
AstraZeneca Sues Aurobindo For Nexium Patent Infringement
AstraZeneca AB slammed Aurobindo Pharma Ltd. with a patent infringement lawsuit in New Jersey federal court on Wednesday over the generics maker's versions of Nexium, claiming the company should be barred from selling the drugs before AstraZeneca's patents and any additional periods of exclusivity expire.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login